OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The need for a clinical case definition in test-negative design studies estimating vaccine effectiveness
Sheena G. Sullivan, Arseniy Khvorov, Xiaotong Huang, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 13
Sheena G. Sullivan, Arseniy Khvorov, Xiaotong Huang, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 13
Showing 13 citing articles:
Effectiveness of rVSV-ZEBOV vaccination during the 2018–20 Ebola virus disease epidemic in the Democratic Republic of the Congo: a retrospective test-negative study
Sophie Meakin, Justus Nsio, Anton Camacho, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 12, pp. 1357-1365
Open Access | Times Cited: 8
Sophie Meakin, Justus Nsio, Anton Camacho, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 12, pp. 1357-1365
Open Access | Times Cited: 8
Evidence base for yearly respiratory virus vaccines: Current status and proposed improved strategies
Mariana Barosa, John P. A. Ioannidis, Vinay Prasad
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 10
Open Access | Times Cited: 3
Mariana Barosa, John P. A. Ioannidis, Vinay Prasad
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 10
Open Access | Times Cited: 3
COVID-19 vaccine effectiveness against the Omicron variant of SARS-CoV-2 in multimorbidity: A territory-wide case-control study
Francisco Tsz Tsun Lai, Vincent Ka Chun Yan, Eric Yuk Fai Wan, et al.
iScience (2024) Vol. 27, Iss. 4, pp. 109428-109428
Open Access | Times Cited: 2
Francisco Tsz Tsun Lai, Vincent Ka Chun Yan, Eric Yuk Fai Wan, et al.
iScience (2024) Vol. 27, Iss. 4, pp. 109428-109428
Open Access | Times Cited: 2
Relative Vaccine Effectiveness of Cell- vs Egg-Based Quadrivalent Influenza Vaccine Against Test-Confirmed Influenza Over 3 Seasons Between 2017 and 2020 in the United States
Alicia Stein, Carrie W Mills, Ian McGovern, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 5
Open Access | Times Cited: 2
Alicia Stein, Carrie W Mills, Ian McGovern, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 5
Open Access | Times Cited: 2
Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022–23 VEBIS multicentre study in Europe
Marine Maurel, Clara Mazagatos, Luise Goerlitz, et al.
Vaccine (2024) Vol. 42, Iss. 16, pp. 3547-3554
Open Access | Times Cited: 2
Marine Maurel, Clara Mazagatos, Luise Goerlitz, et al.
Vaccine (2024) Vol. 42, Iss. 16, pp. 3547-3554
Open Access | Times Cited: 2
Test negative design for vaccine effectiveness estimation in the context of the COVID-19 pandemic: A systematic methodology review
Miceline Mésidor, Yan Liu, Denis Talbot, et al.
Vaccine (2023) Vol. 42, Iss. 5, pp. 995-1003
Closed Access | Times Cited: 6
Miceline Mésidor, Yan Liu, Denis Talbot, et al.
Vaccine (2023) Vol. 42, Iss. 5, pp. 995-1003
Closed Access | Times Cited: 6
Genomic insights into mRNA COVID-19 vaccines efficacy: Linking genetic polymorphisms to waning immunity
Min-Jia Hsieh, Ping‐Hsing Tsai, Pin-Hsuan Chiang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Min-Jia Hsieh, Ping‐Hsing Tsai, Pin-Hsuan Chiang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Bias-interpretability Trade-offs in Vaccine Effectiveness Studies Using Test-negative or Cohort Designs
Mireille E. Schnitzer, Edgar Ortíz‐Brizuela, Mabel Carabalí, et al.
Epidemiology (2023) Vol. 35, Iss. 2, pp. 150-153
Open Access | Times Cited: 3
Mireille E. Schnitzer, Edgar Ortíz‐Brizuela, Mabel Carabalí, et al.
Epidemiology (2023) Vol. 35, Iss. 2, pp. 150-153
Open Access | Times Cited: 3
Influenza epidemiology and vaccine effectiveness during the 2023/2024 season in Italy: A test-negative case-control study
Alexander Domnich, Giancarlo Icardi, Donatella Panatto, et al.
International Journal of Infectious Diseases (2024) Vol. 147, pp. 107202-107202
Open Access
Alexander Domnich, Giancarlo Icardi, Donatella Panatto, et al.
International Journal of Infectious Diseases (2024) Vol. 147, pp. 107202-107202
Open Access
Long-term changes in vaccination protection against severe courses of COVID-19 by non-adapted mRNA-based vaccines
Andreas Beyerlein, Katharina Katz, Helmut Küchenhoff, et al.
Deutsches Ärzteblatt international (2024)
Closed Access
Andreas Beyerlein, Katharina Katz, Helmut Küchenhoff, et al.
Deutsches Ärzteblatt international (2024)
Closed Access
Effectiveness of rVSV-ZEBOV Vaccination During the 2018 - 2020 Ebola Virus Disease Epidemic in the Democratic Republic of the Congo: A Retrospective Observational Analysis
Sophie Meakin, Anton Camacho, Justus Nsio, et al.
(2024)
Closed Access
Sophie Meakin, Anton Camacho, Justus Nsio, et al.
(2024)
Closed Access
Improved Methods for Vaccine Effectiveness Studies
George N. Okoli, Benjamin J. Cowling
The Journal of Infectious Diseases (2024)
Open Access
George N. Okoli, Benjamin J. Cowling
The Journal of Infectious Diseases (2024)
Open Access
Incremental benefit of booster vaccinations for COVID-19 in the United Kingdom
Benjamin J. Cowling, Sheena G. Sullivan
The Lancet Regional Health - Europe (2023) Vol. 35, pp. 100790-100790
Open Access
Benjamin J. Cowling, Sheena G. Sullivan
The Lancet Regional Health - Europe (2023) Vol. 35, pp. 100790-100790
Open Access
